Universal Influenza Vaccine Technology Landscape
The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.
Database
Preclinical
|
Phase 1
|
Phase 2
|
Phase 3
|
Approved
|
|---|---|---|---|---|
|
Platform
Influenza virus-based |
||||
|
13
Vaccines in
Preclinical
|
3
Vaccines in
Phase 1
|
2
Vaccines in
Phase 2
|
0
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
|
|
Platform
Nucleic acid-based |
||||
|
21
Vaccines in
Preclinical
|
11
Vaccines in
Phase 1
|
1
Vaccines in
Phase 2
|
2
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
|
|
Platform
Non-VLP nanoparticles |
||||
|
34
Vaccines in
Preclinical
|
4
Vaccines in
Phase 1
|
2
Vaccines in
Phase 2
|
1
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
|
|
Platform
Recombinant proteins |
||||
|
36
Vaccines in
Preclinical
|
2
Vaccines in
Phase 1
|
1
Vaccines in
Phase 2
|
1
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
| ||||